FDA Inspection 1093604 — Byron L. Lam
The FDA completed an inspection of Byron L. Lam on June 14, 2019 in Miami, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 14, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Miami, FL (United States)
Additional Details
Sponsor-Investigator (S-I)